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LETTER TO EDITOR
Menstrual phase and timing of breast cancer surgery: statistical aspects
Sir - The impact of menstrual cycle-dependent timing of
surgery on long-term outcome of breast cancer patients has
been discussed intensively in this forum by Holli et al. (1995).
Up to the present, the results reported in the literature are
controversial and no clear consensus has been reached. It is
our experience that many colleagues are dissatisfied with the
uncertainty related to this potentially simple and beneficial
therapeutic tool. New arguments would be helpful to explain
the contradictory data reported in the literature. In
accordance with McGuire (1991) and Jager and Sauerbrei
(1995), we feel that the statistical side of the problem is of the
utmost interest, since looking for the optimal splitting of the
menstrual cycle is equivalent to cut-off point searching
involving a cyclic covariate. Referring to this problem
Altman et al. (1994) described 'optimal' cut-off point
searching in connection with a simple continuous prognostic
factor. They reported an approximate formula by Lausen and
Schumacher to be a useful tool for correction of the obtained
minimum P-value.
Since the mathematical theory for an analogous correction
in case of a cyclic covariate, such as the menstrual cycle, is
not yet available, we designed a simulation study using
randomly generated exponentially distributed survival data.
We randomly assigned a menstrual cycle value between 1 and
28 days to every survival time. We varied the sample size
(n = 140, n =280, n = 1400), the amount of censoring (33%
and 67%) and the minimum selection interval (between 7
days and 14 days). When using minimum lengths of the
selection interval ranging from 7 days to 14 days, a total of
210 different partitions were possible. We generated 2000
simulated samples for each of these 210 scenarios.
Neither the sample size nor the amount of censoring had
any remarkable influence on the inflation of type I error rate
(Figure la and b). Choosing a selection interval of 14 days
yielded a type I error rate of about 27% at the common 5%
nominal level. In other words, there were significant results in
one out of four cases, although there was nothing to detect
according to the design of this simulation study. At a
nominal level of 10% and 1% the false-positive rates were
47% and 7.3% respectively (Figure lb). The multiple testing
problem became more evident allowing a minimum selection
interval ranging from 7 to 14 days. The type I error rate
increased to 63% at a nominal level of 5%. Even if we used
the 'impressive' 1% nominal level, we obtained a significant
result in 25% of the tests (Figure la). The simulation study
showed that for achieving an actual type I error rate
(significance level) of approximately 5%, a P-value<0.006
was necessary, using a selection interval of 14 days. This
barrier dropped to a P-value<0.001, when we used minimum
selection intervals ranging from 7 days to 14 days.
In our patient sample (n = 149), we obtained statistically
significant results regarding disease-free and overall survival
using a multiple testing approach for a minimum selection
interval ranging from 7 days to 14 days (smallest P-value
found: 0.011). After correction for type I error using the
according quantiles of the distribution of the minimum P-
value in the 2000 simulated samples, these previously
significant results failed to achieve significance (an uncor-
rected P-value of 0.011 corresponds to a corrected one of
0.27).
In view of the data described above and the works of
Altman et al. (1994), it seems absolutely necessary to
integrate the number of performed tests in the evaluation
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Figure 1 Effect of the minimum P-value approach on the false-
positive rate for selection intervals between 7 days and 14 days (a)
and for a selection interval of 14 days (b). The nominal levels
shown are 10%, 5% and 1%. Each plotted point was obtained
from 2000 simulated samples based on there being no relation
between the menstrual phase and survival, with 33% censoring
(-) and 67% censoring (- -).
of a prognostic factor, which was (even if more tests have
been performed) at least not mentioned by those authors,
who found a statistically significant benefit for menstrual
cycle-dependent timing of surgery on long-term outcome of
breast cancer patients. Our results underline the necessity of
cautious statistical interpretation when dealing with a cyclic
covariate, such as the menstrual cycle.
Yours etc,
G Haeusler
C Tempfer
C Kainz
Department of Gynaecology and Obstetrics
University of Vienna
A-1090, Vienna
H Heinzl
Department of Medical Computer Sciences
University of Vienna
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